Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Trans,trans-2(4-methoxyphenyl)-4-(1-3-benzodiazol-5-yl)-1-(dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic Acid
2. Zd4054
1. 186497-07-4
2. Zd4054
3. Zibotentan (zd4054)
4. Zd-4054
5. 2-(4-(1,3,4-oxadiazol-2-yl)phenyl)-n-(3-methoxy-5-methylpyrazin-2-yl)pyridine-3-sulfonamide
6. N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide
7. Zd 4054
8. Zibotentan (zd4054 )
9. N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-3-pyridinesulfonamide
10. 8054mm4902
11. C19h16n6o4s
12. Zibotentan [usan:inn:jan]
13. Unii-8054mm4902
14. Zibotentanzd4054
15. Zibotentan,zd4054
16. Zibotentan [mi]
17. Zibotentan [inn]
18. Zibotentan [jan]
19. Zibotentan [usan]
20. Zibotentan [mart.]
21. Zd4054 Form 1
22. Zibotentan [who-dd]
23. Mls006011121
24. Schembl847090
25. Zibotentan (jan/usan/inn)
26. Gtpl3539
27. Chembl1628688
28. Zibotentan, >=98% (hplc)
29. Chebi:94573
30. Dtxsid70870171
31. Hms3654h10
32. Bcp02389
33. Bdbm50532593
34. Mfcd09955343
35. S1456
36. Akos015909372
37. Ccg-264894
38. Cs-0492
39. Db06629
40. Sb17118
41. Ncgc00242479-01
42. Ncgc00242479-02
43. Ncgc00242479-03
44. Ncgc00242479-05
45. Ac-32741
46. As-57168
47. Hy-10088
48. Smr004702902
49. Ft-0768122
50. Ns00068495
51. Sw219504-1
52. D07741
53. H11009
54. L001670
55. Q198371
56. Brd-k31553034-001-01-4
57. 3-pyridinesulfonamide, N-(3-methoxy-5-methyl-2-pyrazinyl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl)-
58. 3-pyridinesulfonamide, N-(3-methoxy-5-methylpyrazinyl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl)-
59. N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl)pridine-3-sulfonamide
60. N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2- Yl)phenyl]pyridine-3-sulfonamide
| Molecular Weight | 424.4 g/mol |
|---|---|
| Molecular Formula | C19H16N6O4S |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 6 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 141 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 654 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in prostate cancer.
ABOUT THIS PAGE
83
PharmaCompass offers a list of Zibotentan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zibotentan manufacturer or Zibotentan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zibotentan manufacturer or Zibotentan supplier.
PharmaCompass also assists you with knowing the Zibotentan API Price utilized in the formulation of products. Zibotentan API Price is not always fixed or binding as the Zibotentan Price is obtained through a variety of data sources. The Zibotentan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zibotentan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zibotentan, including repackagers and relabelers. The FDA regulates Zibotentan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zibotentan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zibotentan supplier is an individual or a company that provides Zibotentan active pharmaceutical ingredient (API) or Zibotentan finished formulations upon request. The Zibotentan suppliers may include Zibotentan API manufacturers, exporters, distributors and traders.
Zibotentan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zibotentan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zibotentan GMP manufacturer or Zibotentan GMP API supplier for your needs.
A Zibotentan CoA (Certificate of Analysis) is a formal document that attests to Zibotentan's compliance with Zibotentan specifications and serves as a tool for batch-level quality control.
Zibotentan CoA mostly includes findings from lab analyses of a specific batch. For each Zibotentan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zibotentan may be tested according to a variety of international standards, such as European Pharmacopoeia (Zibotentan EP), Zibotentan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zibotentan USP).
